TrialJournal of diabetes investigation2020

Factors associated with the glucose-lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials.

Naoko Tajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.